Palisade Bio (PALI) Assets Average (2011 - 2026)

Palisade Bio (PALI) has 16 years of Assets Average data on file, last reported at $133.8 million in Q1 2026.

• Assets Average for Q1 2026 came in at $133.8 million, up 1303.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $133.8 million (up 1303.56% YoY), and the FY2025 annual result was $72.6 million, up 482.48% from the prior year.
• Assets Average improved to $133.8 million in Q1 2026 per PALI's latest filing, from $70.7 million in the prior quarter.
• Over five years, Assets Average peaked at $133.8 million in Q1 2026 and troughed at $6.8 million in Q3 2025.
• A 5-year average of $22.8 million and a median of $12.8 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2025 and 2026: Assets Average plunged 41.79% in 2025, then soared 1303.56% in 2026.
• A 5-year view of Assets Average shows it stood at $16.0 million in 2022, then declined by 2.84% to $15.6 million in 2023, then plunged by 35.04% to $10.1 million in 2024, then jumped by 599.04% to $70.7 million in 2025, then soared by 89.4% to $133.8 million in 2026.
• Business Quant data shows PALI's Assets Average at $133.8 million in Q1 2026, $70.7 million in Q4 2025, and $6.8 million in Q3 2025.